Bayer reaches Roundup settlement that could cost the company billions
A judge in Missouri has given final approval to a nationwide settlement that could cost Bayer up to $7.25 billion, paying thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma and allege that its weed killer Roundup caused their cancer. Under the settlement, affected people could receive from $10,000 to $165,000 depending on their exposure to glyphosate, their age at diagnosis, and other factors. Bayer, which denies that Roundup causes cancer, earlier paid roughly $10 billion to $11 billion to settle more than 100,000 related claims, and CEO Bill Anderson calls the new deal a decisive milestone that will mitigate the risks of pending and future litigation.
Judge approves $7.25 billion Roundup cancer settlement
A judge in St. Louis approved a $7.25 billion settlement in the litigation over Bayer's Roundup weed killer, which the report says could bring Bayer closer to ending the long legal battle over tens of thousands of cancer claims. Bayer hailed Judge Timothy Boyer's decision as a 'decisive milestone' and pointed to a recent Supreme Court ruling that made some remaining claims harder to pursue. The report judges the settlement unlikely to end the scientific and political fight over whether Roundup causes cancer, noting the World Health Organization calls glyphosate probably carcinogenic while the United States does not classify it as a carcinogen, and President Trump's 2025 move to protect domestic glyphosate production opened a rift in his coalition. The roundup page also carries short reports on Trump's news conference about possible 2028 successors, an arson conviction in the deadly Palisades Fire, a federal indictment of a Southern California train theft crew, Thanksgiving travel forecasts, and advice on choosing a health plan.
It just got harder to sue over glyphosate
A Missouri judge on Friday granted final approval to Bayer's $7.25 billion settlement of class action lawsuits claiming its weedkiller Roundup causes cancer, and Mother Jones reports the deal will make suing Bayer over Roundup much harder in the future. Bayer, which bought Monsanto in 2018 and inherited roughly 65,000 lawsuits over Roundup's key ingredient glyphosate, has been winning a string of court cases, including a Supreme Court ruling that it could not be held liable for a man's cancer. In a press release, Bayer representatives say the settlement closes the courthouse doors to anyone else seeking restitution and contains no admission of liability or wrongdoing, though Mother Jones reports it may pay individual plaintiffs between $10,000 and $100,000. Christopher A. Seeger, the court-appointed lawyer for the cancer patients, calls the approval a victory that delivers guaranteed compensation to victims who waited more than a decade.
Bayer to pay $11b over claims weed killer caused cancer
A US judge has approved a settlement requiring agrochemical maker Bayer to pay up to $US7.25 billion ($11 billion) over two decades to resolve thousands of claims from US cancer patients who say its weed killer Roundup caused their non-Hodgkin lymphoma. The Missouri settlement covers both people already ill and those diagnosed in future years, with average payouts ranging from $US10,000 to $US165,000, and St Louis Circuit Judge Timothy Boyer called the amounts fair and adequate and the total among the largest mass tort settlements in history. Bayer denies that Roundup causes cancer, and its CEO Bill Anderson called the deal a decisive milestone in managing the litigation, which followed a June US Supreme Court ruling that Bayer cannot be sued in state courts over warning labels. In Australia, by contrast, all class actions over Roundup ended without any compensation payouts, after a Federal Court found insufficient evidence that glyphosate causes the disease.
Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer
A Missouri state court judge gave final approval to a $7.25 billion nationwide settlement ending tens of thousands of lawsuits against Bayer claiming the weedkiller Roundup caused non-Hodgkin lymphoma. People claiming the weedkiller caused their cancer will receive payments of $10,000 to $165,000 depending on severity and other factors, paid from a fund Bayer will fill over 21 years. Bayer inherited the litigation, which grew to around 170,000 suits, when it bought Roundup's maker Monsanto for $63 billion in 2018, and it previously put its litigation costs at least $14 billion. The settlement, reached after a 7-to-2 Supreme Court ruling that Bayer could not be sued in state courts over warning labels, is expected along with that ruling to largely end the legal issues that have dogged Bayer for a decade.
Etats-Unis : un juge valide un accord d’indemnisation par Bayer de 7,25 milliards de dollars pour solder l’ensemble des plaintes liées au Roundup
A judge in Missouri definitively validated on Friday 20 November an agreement under which Bayer will pay up to $7.25 billion (6.6 billion euros) to settle all lawsuits targeting its glyphosate-based herbicide Roundup, accused of causing non-Hodgkin lymphoma. Judge Timothy Boyer of St. Louis had given preliminary approval to the class settlement in March. Bayer said in February that the compensation includes no admission of responsibility or fault. The litigation, which the company inherited when it bought Monsanto, the maker of Roundup, in 2018, has cost it more than $10 billion, amid scientific disagreement over glyphosate: the WHO's cancer agency classifies it as a probable carcinogen, while the US EPA does not consider it carcinogenic. A lawyer for the plaintiffs, Christopher Seeger, said the decision brings guaranteed compensation to victims who waited more than a decade.
US judge approves $7.25 billion Roundup cancer settlement
A judge in a Missouri state court approved Bayer's $7.25 billion settlement of lawsuits claiming its Roundup weedkiller caused blood cancer on Friday, November 20, clearing the way for guaranteed compensation for tens of thousands of Roundup cancer victims. Le Monde and AFP report the settlement is among the largest class recoveries in US history. Bayer has spent billions of dollars settling thousands of Roundup-linked cases since acquiring producer Monsanto in 2018, and still says scientific studies and regulatory approvals show the weedkiller is safe.
RoundUp cancer claims suit settled for $7.25B by Bayer
Bayer agreed to a court-approved settlement of $7.25 billion over cancer claims about its Roundup weedkiller, announced on a Friday afternoon months after the agreement was reached in principle. The class action covered both current and future claims from people exposed to Monsanto's Roundup who developed non-Hodgkin lymphoma, and thousands of people were suing Bayer-owned Monsanto. Plaintiffs' attorney Christopher Seeger said in May that more than 40,000 people could be covered. Bayer had already agreed to a separate $10 billion settlement over similar non-Hodgkin lymphoma claims in 2020.
